Adicet Bio (ACET)

Adicet Bio Stock Analysis & Ratings

ACET Stock Chart & Stats

Day’s Range$9.88 - $10.89
52-Week Range$6.25 - $21.17
Previous Close$10.44
Average Volume (3M)371.34K
Market Cap$207.85M
P/E Ratio-5.1
Next EarningsAug 11, 2022
Next Dividend Ex-DateN/A
Dividend YieldN/A
Smart Score6
EPS (TTM)-2.06



P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.


Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Adicet Bio’s price range in the past 12 months?
Adicet Bio lowest stock price was $6.25 and its highest was $21.17 in the past 12 months.
    What is Adicet Bio’s market cap?
    Adicet Bio’s market cap is $207.85M.
      What is Adicet Bio’s price target?
      The average price target for Adicet Bio is $29.00. This is based on 8 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
      The highest analyst price target is $35.00 ,the lowest forecast is $21.00. The average price target represents 173.33% Increase from the current price of $10.61.
        What do analysts say about Adicet Bio?
        Adicet Bio’s analyst rating consensus is a ‘Strong Buy. This is based on the ratings of 8 Wall Streets Analysts.
          When is Adicet Bio’s upcoming earnings report date?
          Adicet Bio’s upcoming earnings report date is Aug 11, 2022 which is in 80 days.
            How were Adicet Bio’s earnings last quarter?
            Adicet Bio released its earnings results on May 12, 2022. The company reported $0.1 earnings per share for the quarter, beating the consensus estimate of -$0.182 by $0.282.
              Is Adicet Bio overvalued?
              According to Wall Street analysts Adicet Bio’s price is currently Undervalued.
                Does Adicet Bio pay dividends?
                Adicet Bio does not currently pay dividends.
                What is Adicet Bio’s EPS estimate?
                Adicet Bio’s EPS estimate for its next earnings report is not yet available.
                How many shares outstanding does Adicet Bio have?
                Adicet Bio has 19,590,000 shares outstanding.
                  What happened to Adicet Bio’s price movement after its last earnings report?
                  Adicet Bio reported an EPS of $0.1 in its last earnings report, beating expectations of -$0.182. Following the earnings report the stock price went up 11.289%.
                    Which hedge fund is a major shareholder of Adicet Bio?
                    Among the largest hedge funds holding Adicet Bio’s share is Consonance Capital. It holds Adicet Bio’s shares valued at N/A.


                      Adicet Bio Stock Analysis

                      The Adicet Bio stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                      Learn more about TipRanks Smart Score

                      Company Description

                      Adicet Bio

                      resTORbio, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the development and commercialization of medicines for aging-related diseases and conditions. It offers an immunotherapy under the TORC1 program. The company was founded by Chen Schor and Joan Mannick on July 5, 2016 and is headquartered in Boston, MA.

                      Similar Stocks
                      Price & Change
                      Solid Biosciences
                      Cogent Biosciences
                      Unity Biotechnology
                      Xeris Pharmaceuticals

                      Popular Stocks

                      What's Included in PREMIUM?
                      Make informed decisions based on Top Analysts' activity
                      Know what industry insiders are buying
                      Get actionable alerts from top Wall Street Analysts
                      Find out before anyone else which stock is going to shoot up
                      Get powerful stock screeners & detailed portfolio analysis